GEODE CAPITAL MANAGEMENT, LLC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$465,000
-60.3%
483,711
-50.9%
0.00%
Q1 2022$1,172,000
-62.3%
985,231
+3.4%
0.00%
Q4 2021$3,107,000
-18.9%
953,200
+11.1%
0.00%
-100.0%
Q3 2021$3,833,000
-27.2%
857,646
-11.3%
0.00%0.0%
Q2 2021$5,267,000
-15.5%
966,448
+16.0%
0.00%0.0%
Q1 2021$6,230,000
-2.7%
833,008
+41.2%
0.00%0.0%
Q4 2020$6,402,000
+24.7%
590,102
+1.6%
0.00%0.0%
Q3 2020$5,133,000
-14.6%
580,709
+3.0%
0.00%0.0%
Q2 2020$6,010,000
+103.5%
563,801
+13.2%
0.00%0.0%
Q1 2020$2,954,000
-55.1%
498,187
-47.6%
0.00%0.0%
Q4 2019$6,572,000
+40.3%
951,092
+110.7%
0.00%0.0%
Q3 2019$4,685,000
+13.5%
451,425
+1.2%
0.00%0.0%
Q2 2019$4,129,000
+55.5%
445,922
+53.5%
0.00%0.0%
Q1 2019$2,655,000
-4.5%
290,531
-41.8%
0.00%
Q4 2018$2,780,000
+3.1%
499,336
+120.5%
0.00%
-100.0%
Q3 2018$2,696,000
+22.9%
226,434
+5.3%
0.00%0.0%
Q2 2018$2,194,000
+3.3%
214,944
+31.4%
0.00%0.0%
Q1 2018$2,123,000
+128.0%
163,567
+70.8%
0.00%
Q4 2017$931,000
-33.3%
95,755
+0.9%
0.00%
-100.0%
Q3 2017$1,396,000
+3.6%
94,891
+13.2%
0.00%0.0%
Q2 2017$1,348,000
+111.3%
83,821
+109.2%
0.00%
Q1 2017$638,000
+46.7%
40,058
+11.8%
0.00%
Q4 2016$435,000
-9.6%
35,836
+3.1%
0.00%
Q3 2016$481,00034,7500.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders